biguanides has been researched along with Polycystic Ovarian Syndrome in 5 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Various classes of medication are currently being used in Polycystic Ovary Syndrome (PCOS) patients including the biguanides and the statins." | 5.15 | Therapeutic effects of biguanide vs. statin in polycystic ovary syndrome: a randomized clinical trial. ( Fouladi, RF; Navali, N; Nikpour, MA; Pourabolghasem, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kathuria, D | 1 |
| Raul, AD | 1 |
| Wanjari, P | 1 |
| Bharatam, PV | 1 |
| Wang, F | 1 |
| Zhang, Z | 1 |
| Wang, Z | 2 |
| Xiao, K | 1 |
| Wang, Q | 1 |
| Su, J | 1 |
| Navali, N | 1 |
| Pourabolghasem, S | 1 |
| Fouladi, RF | 1 |
| Nikpour, MA | 1 |
| Slocum, JM | 1 |
| Sosa, ME | 1 |
| Galindo García, CG | 1 |
| Vega Arias, Mde J | 1 |
| Hernández Marín, I | 1 |
| Ayala, AR | 1 |
3 reviews available for biguanides and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Biguanides: Species with versatile therapeutic applications.
Topics: Anti-Infective Agents; Antineoplastic Agents; Biguanides; Diabetes Mellitus, Type 2; Female; Humans; | 2021 |
Use of antidiabetes agents in pregnancy: current practice and controversy.
Topics: Administration, Oral; Benzamides; Biguanides; Diabetes, Gestational; Enzyme Inhibitors; Female; Glyc | 2002 |
[Mechanism of action of insulin sensitizer agents in the treatment of polycystic ovarian syndrome].
Topics: Biguanides; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Polycystic Ovary Syndrome; Tria | 2007 |
1 trial available for biguanides and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Therapeutic effects of biguanide vs. statin in polycystic ovary syndrome: a randomized clinical trial.
Topics: Adult; Anticholesteremic Agents; Biguanides; Blood Glucose; Double-Blind Method; Female; Humans; Hyp | 2011 |
1 other study available for biguanides and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Expression and clinical significance of the HIF-1a/ET-2 signaling pathway during the development and treatment of polycystic ovary syndrome.
Topics: Animals; Aromatase Inhibitors; Biguanides; Drug Evaluation, Preclinical; Endothelin-2; Female; Hypox | 2015 |